Advanced Proteome Therapeutics Corp (APC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
52
About the Report
About the Report
Summary
Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.
Advanced Proteome Therapeutics Corp (APC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Advanced Proteome Therapeutics Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Advanced Proteome Raises USD0.1 Million in Venture Financing 13
Advanced Proteome Raises USD0.2 Million in Venture Financing 14
Advanced Proteome Raises USD0.3 Million in Venture Financing 15
Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16
Partnerships 17
Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17
Advanced Proteome Enters into Agreement with ImmunoBiochem 18
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20
Licensing Agreements 21
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22
Equity Offering 23
Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23
Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34
Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35
Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36
Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38
Advanced Proteome Therapeutics Corp-Key Competitors 39
Advanced Proteome Therapeutics Corp-Key Employees 40
Advanced Proteome Therapeutics Corp-Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Corporate Communications 42
Jun 06, 2018: Advanced Proteome Therapeutics Names Bill Dickie As Chief Executive Officer, President And Director 42
Apr 24, 2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members 43
Apr 16, 2018: Advanced Proteome Therapeutics Appoints New Board Members 44
Apr 16, 2018: Advanced Proteome Therapeutics Announces Resignation Of Randal Chase As CEO And Director 45
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 46
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 47
Product News 48
Jun 18, 2018: Advanced Proteome Therapeutics Advances its Technological Capability 48
Other Significant Developments 49
Sep 11, 2018: Advanced Proteome Therapeutics provides overview of current activities and strategic objectives 49
May 01, 2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018 50
Jan 31, 2018: Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
List of Figure
List of Figures
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Advanced Proteome Therapeutics Corp, Medical Devices Deals, 2012 to YTD 2018 10
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Advanced Proteome Raises USD0.1 Million in Venture Financing 13
Advanced Proteome Raises USD0.2 Million in Venture Financing 14
Advanced Proteome Raises USD0.3 Million in Venture Financing 15
Advanced Proteome Therapeutics Raises USD 0.04 Million In Venture Financing 16
Advanced Proteome Therapeutics Enters into Collaboration Agreement with Noria Pharma 17
Advanced Proteome Enters into Agreement with ImmunoBiochem 18
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 19
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 20
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 21
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 22
Advanced Proteome Therapeutics Raises USD0.2 Million in First Tranche Private Placement of Units 23
Advanced Proteome Raises USD0.1 Million in Second Tranche of Private Placement of Units 24
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 25
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 26
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 27
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 28
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 29
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 31
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 32
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 33
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 34
Advanced Proteome Therapeutics Completes Private Placement Of Shares For USD 0.2 Million 35
Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.7 Million 36
Advanced Proteome Therapeutics Completes Private Placement Of Units For USD 0.3 Million 37
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For USD 0.2 Million 38
Advanced Proteome Therapeutics Corp, Key Competitors 39
Advanced Proteome Therapeutics Corp, Key Employees 40
Advanced Proteome Therapeutics Corp, Other Locations 41
Advanced Proteome Therapeutics Corp, Subsidiaries 41
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.